RxDoctor Payments Data

Roberta Monroe, NP

Family · Spartanburg, SCNPI 1497225346

Payments from drug & device makers

$1,479in general payments, 2019–2025

Across 93 payments — averaging $15.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$376
  • Alkermes, Inc.$274
  • Johnson & Johnson$209
  • E.r. Squibb & Sons, L.L.C.$170
  • Teva Pharmaceuticals USA, Inc.$161
  • Otsuka America Pharmaceutical, Inc.$85
  • plus $203 from 7 others

What the payments were for

  • Food & beverage$1,479100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,479 in reported general payments places this provider in the 70th percentile of 3,248 family providers in South Carolina.

See all family providers in South Carolina

Medicare billing

Part B allowed, 2024
$8,694
Medicare patients
30
Services billed
99

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate64$228,934
FanaptIloperidone11$37,403
Abilify MaintenaAripiprazole13$34,462
GeodonZiprasidone Hcl23$28,972
VraylarCariprazine Hcl20$27,037
Wellbutrin XlBupropion Hcl13$26,084
ZyprexaOlanzapine13$18,875
Lurasidone Hcl36$7,703
RisperdalRisperidone12$6,539
Divalproex Sodium ErDivalproex Sodium39$3,393
Ziprasidone Hcl60$2,598
Perphenazine11$2,583
Olanzapine87$1,900
Quetiapine Fumarate58$1,681
Paliperidone ErPaliperidone14$1,661

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna, Risperdal$209$235,47376 claims
Vanda Pharmaceuticals Inc.Fanapt$65$37,40311 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$85$34,46213 claims
AbbVieVraylar$376$27,03720 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,248 family providers in South Carolina.

Other family in Spartanburg

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →